Drugs / STR-P005
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07655453 | Aug 2026 → Jul 2027 expected | — | Starna Therapeutics | Not yet recruiting | No outcome recorded |
| — | NCT07605637 | Jun 2026 → May 2027 expected | immune dysregulation, autoimmunity, and autoinflammation | Beijing GoBroad Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STR-P005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07655453 ↗ |
| Route | Intravenous | “multiple, multi-cycle intravenous infusions” NCT07655453 ↗ |